187 Pill - yellow round, 9mm
Pill with imprint 187 is Yellow, Round and has been identified as Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 100 mg. It is supplied by Sun Pharmaceuticals.
Carbidopa/levodopa is used in the treatment of Parkinson's Disease; Neuroleptic Malignant Syndrome; GTP-CH Deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 187
Carbidopa and Levodopa (Orally Disintegrating)
- Imprint
- 187
- Strength
- 25 mg / 100 mg
- Color
- Yellow
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceuticals
- Inactive Ingredients
-
povidone,
mannitol,
calcium silicate,
crospovidone,
magnesium silicate,
magnesium stearate,
aspartame,
silicon dioxide,
microcrystalline cellulose,
D&C Yellow No. 10,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 47335-0187 | Sun Pharmaceutical Industries Inc. |
| 62756-0187 (Discontinued) | Sun Pharmaceutical Industries Inc. |
Related images for "187"
More about carbidopa / levodopa
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (94)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
Other brands
Sinemet, Rytary, Crexont, Sinemet CR, ... +3 more
Professional resources
- Levodopa/Carbidopa monograph
- Carbidopa and Levodopa (FDA)
- Carbidopa and Levodopa ODT (FDA)
- Carbidopa and Levodopa Tablets (FDA)
Other brands
Sinemet, Rytary, Crexont, Sinemet CR, ... +3 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.